Comparison of hydroxocobalamin with other resuscitative fluids in volume-controlled and uncontrolled hemorrhage models in swine ( Sus-scrofa ).
Journal
The journal of trauma and acute care surgery
ISSN: 2163-0763
Titre abrégé: J Trauma Acute Care Surg
Pays: United States
ID NLM: 101570622
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
medline:
27
7
2023
pubmed:
18
5
2023
entrez:
18
5
2023
Statut:
ppublish
Résumé
Traumatic hemorrhage is the leading cause of preventable death in military environments. Treatment with resuscitative fluids and blood components is based on availability, thus, frequently unavailable in the prehospital setting, due to lack of resources and costs. Hydroxocobalamin (HOC), increases blood pressure via nitric oxide scavenging. We evaluated HOC as a resuscitation fluid, in two swine hemorrhage models. Our objectives were to (1) evaluate whether HOC treatment following hemorrhagic shock improves hemodynamic parameters and (2) determine whether those effects are comparable to whole blood (WB) and lactated ringers (LR). Yorkshire swine (S us scrofa ) (n = 72) were used in models of controlled hemorrhage (CH) (n = 36) and uncontrolled hemorrhage (UH) (n = 36). Randomized animals received treatment with 500 mL of either WB, LR, HOC (150 mg/kg), followed by a six-hour observation (n = 6 each group). Survival, hemodynamics, blood gases (ABGs) and chemistries were collected. Data reported as mean ± standard error of the mean and statistical analysis by ANOVA ( p < 0.05). Blood loss for CH was 41% ± 0.02 versus 33% ± 0.07 for UH. For CH, HOC treatment maintained higher systolic blood pressure (sBP, mm Hg) compared with WB and LR (72 ± 1.1; 60 ± 0.8; 58 ± 1.6; respectively). Heart rate (HR), cardiac output (CO), Sp o2 and vascular resistance were comparable with WB and LR. The ABG values were comparable between HOC and WB. For UH, HOC treatment maintained sBP levels comparable to WB and higher than LR (70 ± 0.9; 73 ± 0.5; 56 ± 1.2). HR, CO, Sp o2 , and systemic vascular resistance were comparable between HOC and WB. Survival, hemodynamics, blood gases were comparable between HOC and WB. No survival differences were found between cohorts. Hydroxocobalamin treatment improved hemodynamic parameters and Ca 2+ levels compared with LR and equivalent to WB, in both models. Hydroxocobalamin may be a viable alternative when WB is not available.
Sections du résumé
BACKGROUND
Traumatic hemorrhage is the leading cause of preventable death in military environments. Treatment with resuscitative fluids and blood components is based on availability, thus, frequently unavailable in the prehospital setting, due to lack of resources and costs. Hydroxocobalamin (HOC), increases blood pressure via nitric oxide scavenging. We evaluated HOC as a resuscitation fluid, in two swine hemorrhage models. Our objectives were to (1) evaluate whether HOC treatment following hemorrhagic shock improves hemodynamic parameters and (2) determine whether those effects are comparable to whole blood (WB) and lactated ringers (LR).
METHODS
Yorkshire swine (S us scrofa ) (n = 72) were used in models of controlled hemorrhage (CH) (n = 36) and uncontrolled hemorrhage (UH) (n = 36). Randomized animals received treatment with 500 mL of either WB, LR, HOC (150 mg/kg), followed by a six-hour observation (n = 6 each group). Survival, hemodynamics, blood gases (ABGs) and chemistries were collected. Data reported as mean ± standard error of the mean and statistical analysis by ANOVA ( p < 0.05).
RESULTS
Blood loss for CH was 41% ± 0.02 versus 33% ± 0.07 for UH. For CH, HOC treatment maintained higher systolic blood pressure (sBP, mm Hg) compared with WB and LR (72 ± 1.1; 60 ± 0.8; 58 ± 1.6; respectively). Heart rate (HR), cardiac output (CO), Sp o2 and vascular resistance were comparable with WB and LR. The ABG values were comparable between HOC and WB. For UH, HOC treatment maintained sBP levels comparable to WB and higher than LR (70 ± 0.9; 73 ± 0.5; 56 ± 1.2). HR, CO, Sp o2 , and systemic vascular resistance were comparable between HOC and WB. Survival, hemodynamics, blood gases were comparable between HOC and WB. No survival differences were found between cohorts.
CONCLUSION
Hydroxocobalamin treatment improved hemodynamic parameters and Ca 2+ levels compared with LR and equivalent to WB, in both models. Hydroxocobalamin may be a viable alternative when WB is not available.
Identifiants
pubmed: 37199527
doi: 10.1097/TA.0000000000004049
pii: 01586154-990000000-00380
pmc: PMC10389457
doi:
Substances chimiques
Gases
0
Hydroxocobalamin
Q40X8H422O
Isotonic Solutions
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
S120-S128Informations de copyright
Copyright © 2023 Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.
Références
N Engl J Med. 1994 Oct 27;331(17):1105-9
pubmed: 7935634
J Trauma. 2008 Feb;64(2 Suppl):S28-37; discussion S37
pubmed: 18376169
J Trauma. 2006 Mar;60(3):655-8
pubmed: 16531872
Transfusion. 2011 Apr;51(4):779-92
pubmed: 21091492
Ann Emerg Med. 2014 Dec;64(6):612-9
pubmed: 24746273
Mil Med. 1970 Jan;135(1):8-13
pubmed: 4985194
Ann Surg. 2007 Jun;245(6):986-91
pubmed: 17522526
Ann Pharmacother. 2008 May;42(5):661-9
pubmed: 18397973
Injury. 2012 May;43(5):638-47
pubmed: 21094491
Ann Surg. 2011 Mar;253(3):431-41
pubmed: 21178763
Acad Emerg Med. 2017 Sep;24(9):1088-1098
pubmed: 28472554
J Trauma. 2007 Oct;63(4):805-13
pubmed: 18090009
Cochrane Database Syst Rev. 2013 Jul 23;(7):CD007594
pubmed: 23881659
Mil Med. 2018 Nov 5;183(11-12):e721-e729
pubmed: 30500921
J Med Toxicol. 2020 Oct;16(4):388-397
pubmed: 32239422
J Surg Res. 2007 Dec;143(2):276-80
pubmed: 17574590
J Appl Physiol (1985). 2008 Oct;105(4):1076-82
pubmed: 18635878
J Trauma. 2011 Jul;71(1 Suppl):S131-8
pubmed: 21795889
Curr Opin Anaesthesiol. 2008 Apr;21(2):216-21
pubmed: 18443492
Acad Emerg Med. 2015 Mar;22(3):321-30
pubmed: 25731610
Acad Emerg Med. 2014 Nov;21(11):1203-11
pubmed: 25377396
J Trauma. 1995 Feb;38(2):185-93
pubmed: 7869433
Anesthesiology. 2004 Aug;101(2):399-408
pubmed: 15277923
Clin Exp Pharmacol Physiol. 2019 Mar;46(3):216-225
pubmed: 30575111
J Emerg Med. 2019 Jun;56(6):687-697
pubmed: 31010604
Shock. 2013 Feb;39(2):210-9
pubmed: 23324891
Crit Care Med. 2008 Jul;36(7 Suppl):S258-66
pubmed: 18594251
J Surg Res. 2013 Sep;184(1):414-21
pubmed: 23831230
JAMA. 2008 May 21;299(19):2304-12
pubmed: 18443023